Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational study
{{output}}
Background: Type 2 diabetes mellitus (T2DM) is a major risk factor for neurocognitive impairment, with delirium predicting dementia. While metformin may offer neuroprotection, prior studies face selection bias. This study examine... ...
